• 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis
• 2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review
• A Novel Approach to Cardiac Magnetic Resonance Scar Characterization in Patients Affected by Cardiac Amyloidosis: A Pilot Study
• A rare variant in the TTR gene (p.E112K) is associated with systemic amyloidosis and a new symptom - skin hyperemia in response to ethanol intake: family segregation analysis, literature review, and a clinical case. Case report
• Adherence and persistence to tafamidis treatment among Medicare beneficiaries in the presence of a patient assistance program
• Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings
• Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review
• Amyloidosis
• An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis
• Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
• Assessment of incidental cardiac uptake in bone scintigraphy across Spain: The ECCINGO study
• Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model
• Associations of Patients with Pericardial Effusion Secondary to Light-Chain or Transthyretin Amyloidosis- A Systematic Review
• Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature
• ATTR Gene Variants in HCM
• Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv)
• Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy
• Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT/CT and semiquantitative planar parameters
• Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis
• Cardiopulmonary exercise testing in transthyretin amyloid cardiomyopathy patients: a long-term follow-up study
• Case Report: A rare transthyretin mutation p.D58Y in a Chinese case of transthyretin amyloid cardiomyopathy
• Case Report: Transthyretin Glu54Leu-a rare mutation with predominant cardiac phenotype
• Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells
• Characterization of Transthyretin Mutation G47V Associated with Hereditary Cardiac Amyloidosis
• Chemistry, Biological Properties, and Bio-analysis of Tafamidis, a New Transthyretin Stabilizer: A Systematic Review
• Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis
• Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of Sao Paulo, Brazil (REACT-SP)
• Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
• Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study
• Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy
• Clinical case of generalized amyloidosis (ATTR-amyloidosis) with a progressive course of chronic heart failure. Case report
• Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease
• Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis
• Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy
• Current Perspectives on Atrial Amyloidosis: A Narrative Review
• Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis
• Deep Learning-Enabled Quantification of (99m)Tc-Pyrophosphate SPECT/CT for Cardiac Amyloidosis
• Detection of cardiac amyloidosis on routine bone scintigraphy: an important gatekeeper role for the nuclear medicine physician
• Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis
• Diagnostic Modalities in the Detection of Cardiac Amyloidosis
• Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study
• Distinctive Deposition Patterns of Sporadic Transthyretin-Derived Amyloidosis in the Atria: A Forensic Autopsy-Based Study
• Dual AApoAIV amyloidosis and ATTR amyloidosis arising in the same patient: a report of three cases
• Effect of tafamidis on left atrial function of patients with transthyretin amyloid cardiomyopathy
• Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation
• Epidemiological study of the subtype frequency of systemic amyloidosis listed in the Annual of the Pathological Autopsy Cases in Japan
• Epidemiology, diagnosis, and management of cardiac amyloidosis
• Eplontersen: First Approval
• Examining the Difficulties in Identifying and Handling Cardiac Amyloidosis; Acquiring Important Knowledge and Robust Treatment Methods
• EXPRESS: Epidemiology, Diagnosis and Management of Cardiac Amyloidosis
• Familial occurrences of cardiac wild-type transthyretin amyloidosis: a case series
• Gait abnormalities in older adults with transthyretin cardiac amyloidosis
• Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation
• Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update
• Hereditary transthyretin amyloidosis presenting with prominent autonomic dysfunction
• Identification of the interfacial regions in misfolded transthyretin oligomers
• Incremental prognostic utility of congestion markers in cardiac transthyretin amyloidosis
• Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils
• Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
• Musculoskeletal Amyloidosis Imaging
• Musculoskeletal co-morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review
• Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of TTR V142I with Heart Failure and/or Arrhythmia
• Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real-World Data
• Patisiran
• Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study
• Phenotype and prognostic factors in geriatric and non-geriatric patients with transthyretin cardiomyopathy
• Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
• Predictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosis
• Primary Data on ATTR-Amyloidosis Prevalence Among Elderly Patients With Left Ventricular Hypertrophy in Russia
• Prognostic Value of [^99mTc]Tc-DPD Quantitative SPECT/CT in Patients with Suspected and Confirmed Amyloid Transthyretin-Related Cardiomyopathy and Preserved Left Ventricular Function
• Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis
• Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis
• Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis
• Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects
• Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy
• Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis
• Recurrent ventricular tachycardia in a patient with A19D mutation-associated hereditary transthyretin amyloidosis: a case report
• Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval
• RNA Interference Therapeutics for Hereditary Amyloidosis: A Narrative Review of Clinical Trial Outcomes and Future Directions
• Scintigraphic and Echocardiographic Study of Patients with Pathogenic or Probably Pathogenic Variants of the TTR Gene without Overt Cardiac Involvement
• Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice
• Sex Differences in Transthyretin Cardiac Amyloidosis: Unraveling the Complexities in Epidemiology, Pathophysiology, Diagnosis, and Treatment
• SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy
• Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review
• Sodium-glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: Analyses of short-term efficacy and safety
• Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis
• Structures and Dynamics of beta-Rich Oligomers of ATTR (105-115) Assembly
• Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis
• Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones
• Temporal implementation of a regional referral pathway in transthyretin cardiac amyloidosis: Emilia-Romagna experience
• The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
• Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019)
• Transthyretin Cardiac Amyloidosis in an Elderly Male With Heart Failure Intolerant to Guideline-Directed Medical Therapy
• Transthyretin-derived amyloid (ATTR) and sarcoidosis: Does ATTR deposition cause a granulomatous inflammatory response in older adults with sarcoidosis?
• Treatment of transthyretin cardiac amyloidosis
• Turning Meters Into Years: Walking to Survive Transthyretin Cardiac Amyloidosis
• Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
• Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease
• Wild-Type Transthyretin Amyloidosis: A Prevalent and Underdiagnosed Cause of Heart Failure With Preserved Ejection Fraction
• Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study